Delivery Order SPE2DB22D3011-SPE2DB23FQ0NL
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,400.64 fixed-price contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,350.17 award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The delivery order was issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,620.35 contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdoses. The contract has an ultimate completion date of January 20, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.64, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract is a firm-fixed-price delivery order, and does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a larger...
- This is a Delivery Order with a Firm Fixed Price contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $9,067.74. The contract is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product used to treat opioid overdose. The contract has an Ultimate Completion Date of February 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,489.88 contract is to provide NARCAN 4 MG NASAL SPRAY 2S, a medication used to reverse opioid overdose. This is a single award under the DLA's $999,999,999 Indefinite Delivery Contract (IDC) with AmerisourceBergen, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,392.96 contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.13, is for the delivery of NARCAN 4 MG NASAL 2S, a medication used to treat opioid overdose. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,561.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This is a $2,530.77 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide NARCAN 4 MG NASAL SPRAY 2S. The contract has a performance period through July 7, 2025 and is not set aside. Amerisourcebergen also holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, allowing the company to supply a wide range of pharmaceutical products...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB23FQ0NLDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,463.04 contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The award is not associated with a set-aside program and does not appear to be part of a larger indefinite delivery contract vehicle. However, the vendor does hold a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary mechanism for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely one of many such awards made under that larger contracting vehicle to ensure the availability of essential medical commodities for federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/18/23 |